Archon Partners’s Neurogene NGNE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-945	Closed	-$268K	–	62
2017 Q3	$268K	Buy	945 +45	+5%	+$12.8K	0.06%	57
2017 Q2	$253K	Buy	900 +275	+44%	+$77.3K	0.06%	57
2017 Q1	$209K	Buy	+625	New	+$209K	0.05%	59